An alternative hypothesis to the model presented here is that deletion of LDLR is maximally deleterious to mouse models of lipid metabolism, which precludes further worsening of dyslipidemia by CETP and other targets governing TG metabolism. The gene discussed is LDLR; the disease is metabolic syndrome.